{"product_id":"pbk-spk-antibody-sc-f3332","title":"PBK\/SPK Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003ePBK\/SPK is a target of interest in many antibody-based workflows. PBK (PDZ-binding kinase)\/SPK (serine\/threonine-protein kinase), also known as T-LAK cell-originated protein kinase (TOPK), is a dual-specificity MAPKK family member that functions as a critical mitotic kinase and signaling regulator in both normal and pathological states. PBK contains a conserved serine\/threonine kinase catalytic domain and a PDZ-binding motif, facilitating interactions with various proteins to coordinate phosphorylation events essential for cell cycle progression, especially during the G2\/M phase. Depending on the literature source, PBK\/SPK may also be discussed as PBK\/SPK and TOPK.\u003c\/p\u003e\u003cp\u003eReported cellular context includes nucleus, which can matter when signal is compared across treatments or changing cell states. Following PBK\/SPK across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003ePBK\/SPK is commonly interpreted in the context of cancer, immunology, and cell cycle research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003esignal enrichment within nucleus relative to the broader cellular background\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003econtext differences tied to immune-cell state, activation, or lineage composition\u003c\/li\u003e\n\u003cli\u003ecell-cycle linked differences in abundance, timing, or compartmental enrichment\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for PBK\/SPK. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in PBK\/SPK reflect biology rather than handling. When interpreting PBK\/SPK, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep PBK\/SPK trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57578015555929,"sku":"F3332-20UL","price":129.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57578015588697,"sku":"F3332-100UL","price":299.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57578015621465,"sku":"F3332-2X100UL","price":449.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F3332-wb.gif?v=1773601120","url":"https:\/\/absource.de\/products\/pbk-spk-antibody-sc-f3332","provider":"Absource Diagnostics","version":"1.0","type":"link"}